2017 One Health Innovations Symposium

 View Agenda 

August 27-28, 2017

Kansas City Convention Center
301 W 13th St. 2100 Entrance, Room 2103 A
Kansas City, MO 64105

The Kansas City Area Life Sciences Institute, in collaboration with Kansas State University and the University of Missouri, arranged for over 20 speakers to present at the 2017 One Health Innovations symposium with the theme of  “Preventing the Next Pandemic.” This symposium featured an outstanding slate of speakers and presentations addressing the topic from two perspectives, predictive biology and vaccine platforms.

This program was reviewed and approved by the Kansas State University College of Veterinary Medicine program for meeting the requirement of nine (9) total hours of continuing education credit in jurisdictions which recognize Kansas State University College of Veterinary Medicine approval. 

Keynote Speakers

One Health: An Increasingly Popular Approach to Wicked Global Health Problems

Gregory Gray, MD, MPH, FIDSA
Professor, Medicine, Environmental Health and Global Health
Duke University
View Biography and Abstract »



Zika Vaccine Development: Starting from Scratch

Mark Challberg, PhD
Program Officer, Virology Branch, Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
View Biography and Abstract »

Endnote Speaker

National Bio and Agro-defense Facility (NBAF): A New Paradigm

Marty Vanier, DVM
Director, Partnership Development
National Bio and Agro-defense Facility (NBAF)
Kansas State University
View Biography and Abstract »


Day 1
The predictive biology segment explored surveillance and big data approaches targeting early disease identification and intervention. Dr. Tracey McNamara, the pathologist who first identified West Nile virus in the United States, and Dr. Jorge Soberon discussed disease spread using ecology and evolutionary biology. Surveillance methods used in Africa was be presented by Dr. Jean Paul Gonzalez. Experts using computational biology, genomic and social data presented how these technologies can be integrated to prevent pandemics.

Day 2
The second day of the research symposium showcased different vaccine platform approaches for highly pathogenic avian influenza , MERS, Zika and Ebola. Dr. Scott McVey an expert in regulatory science discussed fast-track approaches for emerging diseases and Dr. Samuel Thevasagayam from the Gates Foundation discussed challenges of manufacturing in Sub-Saharan Africa. Novel approaches including synthetic mRNA and interferon was also presented as alternatives for controlling zoonotic diseases.